Empire Life Investments Inc. cut its position in Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.1% in the fourth quarter, HoldingsChannel reports. The institutional investor owned 157,000 shares of the medical research company’s stock after selling 1,728 shares during the period. Empire Life Investments Inc.’s holdings in Exact Sciences were worth $7,773,000 at the […]
Northstar Group Inc. purchased a new position in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) in the 4th quarter, Holdings Channel reports. The institutional investor purchased 5,321 shares of the medical research company’s stock, valued at approximately $263,000. Several other large investors have also recently added to or reduced their stakes in EXAS. […]
Exact Sciences Co. (NASDAQ:EXAS – Get Rating) EVP Sarah Condella sold 1,000 shares of the firm’s stock in a transaction that occurred on Monday, April 3rd. The stock was sold at an average price of $67.19, for a total transaction of $67,190.00. Following the sale, the executive vice president now owns 86,692 shares in the […]
Thompson Investment Management Inc. lessened its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 1.1% in the 4th quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 196,693 shares of the medical research company’s stock after selling 2,285 shares during the […]
Quantum Private Wealth LLC trimmed its stake in shares of Exact Sciences Co. (NASDAQ:EXAS – Get Rating) by 2.4% in the fourth quarter, according to the company in its most recent filing with the SEC. The firm owned 58,163 shares of the medical research company’s stock after selling 1,413 shares during the quarter. Exact Sciences […]